1. Hess C，Stratmann B，Quester W，et al.Clinical and forensic examinations of glycemic marker 1，5-anhydroglucitol by means of high performance liquid chromatography tandem mass spectrometry.Forensic Sci Int，2012 222（1-3）：132-136.

2. Kim WJ，Park CY.1，5-Anhydroglucitol in diabetes mellitus. Endocrine，2012 Jul 31. DOI：10. 1007/s12020-012-9760-6.

3. Juraschek SP，Steffes MW，Miller ER 3rd，et al.Alternative markers of hyperglycemia and risk of diabetes.Diabet Care，2012 Aug doi：10.2337/dc12-0787.

4. Stettler C，Stahl M，Allemann S，et al.Association of 1，5-anhydroglucitol and 2-h postprandial blood glucose in Type 2 diabetic patients.Diabet Care，2008，31（8）：1534-1535.

5. Jing F，Jun L，Wang Y，et al.A novel fully enzymatic method for determining glucose and 1，5-anhydro-D-glucitol in serum of one cuvette.Appl Biochem Biotechnol，2008，150 （3）：327-335.

6. Akutsu T，Mori Y，Itoh Y，et al.1，5-anhydroglucitol and postprandial hyperglycemia as assessed by self-monitoring of blood glucose in Japanese patients with moderately controlled diabetes.Diabetes，2007，56（Suppl.1）：112A.

7. Dungan KM，Buse JB，Largay J，et al.1，5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.Diabet Care，2006，29：1214-1219.

8.张孝山，李玉运.1，5-脱水山梨醇的性质及其临床应用.中国医学检验杂志，2006，7（1）：57-58.

9. Kawasaki I，Sato T，Hosoi M，et al.Serum 1，5-anhydroglucitol is a strong predictor of the postprandial hyperglycemia in type 2 diabetes patients（Abstract）.Diabetes，2005，54 （Suppl.1）：76A.

10. McGill JB，Cole TG，Nowatzke W，et al.Circulating 1，5-Anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia.Diabet Care，2004，27：1859-1865.

11. Yamanouchi T，Inoue T，Ogata E，et al.Post-load glucose measurements in oral glucose tolerance tests correlate well with 1，5-anhydroglucitol，an indicator of overall glycaemic state，in subjects with impaired glucose tolerance. Clin Sci，2001，101：227-233.

12. Stratton IM，Adler AI，Neil HA，et al.Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes（UKPDS 35）：prospective observational study.BMJ，2000，321：405-412.

13. Tomomi Fujisawa，Hiroshi Ikegami，Takanori Tsutsui，et al.Renal tubular function affects glycosuria-related urinary excretion of 1，5-anhydroglucitol. Diabet Care，1999，22 （5）：863-864.

14. Kilpatrick ES，Keevilt BG，Richmond KL，et al.Plasma 1，5-anhydroglucitol concentrations are influenced by variation in the renal threshold for glucose.Diabet Med，1999，16：496-499.

15.方京冲，史虹莉，杨秀芳，等.一种新的糖代谢指标——血清1，5-脱水山梨醇.中华内分泌代谢杂志，1998，14 （3）：175-179.

16. UK Prospective Diabetes Study（UKPDS）Group.Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes（UKPDS 33）.Lancet，1998，352：837-853.

17. Sticklas D，Turk J.A kinetic mass balance model for 1，5-anhydroglucitol：applications to monitoring of glycemic control.Am J Physiol Endocrinol Metab，1997，273：821-830.

18. Dauglas Stickle，John Turk.A kinetic mass balance model for 1，5-anhydroglucitol：applications to monitoring of glycemic control.Am J Physiol，1997，273：E821-830.

19. Yamanouchi T，Ogata N，Tagaya T.Clinical usefulness of serum 1，5-anhydroglucital in monitoring glycaemic control.Lancet，1996，347：1514-1518.

20. Schlichtkrull J，Munck O，Jersild M et al.The M-value，an index of blood-sugar control in diabetics. Acta Med Scand，1996，177：95-102.

21.糖尿病检测新指标：1，5-脱水山梨醇.实用糖尿病杂志，1996，4（2）：58-60.

22. Ohkubo Y，Kishikawa H，Araki E，et al.Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus：a randomized prospective-6-year study.Diabetes Res Clin Pract，1995，28（2）：103-117.

23. S.Tsuki，I.Kobayashi.Effects of age and obesity on glycated haemoglobin and 1，5-anhydroglucitol in screening for type 2 diabetes mellitus.Diabet Med，1995，12：899-903.

24. Koshimoto M，Yamasaki Y，Arai K，et al.1，5-anhydro-D-glucitol evaluates daily glycemic excursions daily glycemic excursions in well-controlled NIDDM. Diabet Care，1995，18（8）：1156-1159.

25.邱文生.1，5-脱水山梨醇的基础与临床.中国糖尿病杂志，1995，20：104-106.

26.李怡，邱文升，李文瑞.血清1，5-脱水山梨醇测定用于糖尿病监测新指标及其临床意义.中国糖尿病杂志，1995，20：89-92.

27. Phillipou G，James SK，Frith RG，et al.Enzymatic quantification of 1，5-anhydro-D-glucitol：evaluation and clinical application.Clin Chem，1994，40（7）：1322-1326.

28. DCCT Research Group.The effect of intensive treatment of diabetes on the development and progression of Long-term complications in IDDM. N Eng J Med，1993，329：977-982.

29. Yamanouchi T，Moromizawa H，Shinohara T，et al.Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1，5-anhydroglucitol.Metabolism，1992，41：862-867.

30. Tanaka S，Nakamari K，Akanuma H，et al.High performance liquid chromatographic determination of 1，5-anhydroglucitol in human plasma for diagnosis of diabetes mellitus.Biomed Chromatogr，1992，6：63-66.

31. Yamanouchi T，Akanuma Y，Toyota T，et al.Comparison of 1，5-anhydroglucitol，HbA1c，and fructosamine for detection of diabetes mellitus.Diabetes，1991，40：52-57.

32. Yamanouchi T，Akaoka I，Akanuma Y，et al.Mechanism for acute reduction of 1，5-anhydroglucitol in rats treated with diabetogenic agents.Am J Physiol，1990，258：E423-427.

33. Yamanouchi T，Minoda S，Yabuuchi M，et al.Plasma 1，5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients.Diabetes，1989，38：723-729.

34. Yabuuchi M，Masuda M，Katoh K，et al.Simple enzymatic method for determining 1，5-anhydro-D-glucitol in plasma for diagnosis of diabetes mellitus.Clin Chem，1989，35：2039-2043.

35. Yamanouchi T，Akanuma H，Nakamura T，et al.Reduction of plasmal 5-anhydrogucitol（1-deoxyglucose）concentration in diabetic patients.Diabetlogia，1988，31：41-45.

36. Akanuma Y，Morita M，Fukuzawa N，et al.Urinary excretion of 1，5-anhydro-D-glucitolaccompanying glucose excretion in diabetic patients. Diabetologia，1988，31：831-835.